Search

The COVID-19 pandemic has clearly shown the importance of developing advanced protective equipment, and new antiviral fabrics for the protection and prevention of life-threatening viral diseases are needed. In this study, selenium nanoparticles (SeNPs) were combined with polyester fabrics using printing technique to obtain multifunctional properties, including combined antiviral and antibacterial activities as well as coloring. The properties of the printed polyester fabrics with SeNPs were estimated, including tensile strength and color fastness. Characterization of the SeNPs was carried out using TEM and SEM. The results of the analysis showed good uniformity and stability of the particles with sizes range from 40-60 nm and 40-80 nm for SeNPs 25 mM and 50 mM, respectively, as well as uniform coating of the SeNPs on the fabric. In addition, the SeNPs-printed polyester fabric exhibited high disinfection activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with an inhibition percentage of 87.5%. Moreover, a toxicity test of the resulting printed fabric revealed low cytotoxicity against the HFB4 cell line. In contrast, the treated fabric under study showed excellent killing potentiality against Gram-positive bacteria ( Bacillus cereus ) and Gram-negative bacteria ( Pseudomonas aeruginosa, Salmonella typhi, and Escherichia coli ). This multifunctional fabric has high potential for use in protective clothing applications by providing passive and active protection pathways.

In this study, we developed a new approach for depositing selenium nanoparticles (SeNPs) into polypropylene (PP) fabrics via a one-step process under hydrothermal conditions by using an IR-dyeing machine to incorporate several functionalities, mainly coloration, antibacterial activity and ultraviolet (UV) protection. The formation, size distribution, and dispersion of the SeNPs were determined using X-ray diffraction (XRD), ultraviolet-visible (UV/Vis), transmission electron microscopy (TEM) and the color strength, fastness, antibacterial properties, and UV protection of the treated fabrics were also explored. The UV-Vis spectra and TEM analysis confirmed the synthesis of spherical well-dispersed SeNPs and the XRD analysis showed the successful deposition of SeNPs into PP fabrics. The obtained results demonstrate that the SeNPs-PP fabrics is accompanied by a noticeable enhancement in measurements of color strength, fastness, and UV-protection factor (UPF), as well as excellent antibacterial activity. Viability studies showed that SeNPs-PP fabrics are non-toxic against wi-38cell line. In addition, the treated SeNPs-PP fabrics showed an increase in conductivity. The obtained multifunctional fabrics are promising for many industrial applications such as the new generation of curtains, medical fabrics, and even automotive interior parts.

We report the outcomes of secondary acute myeloid leukemia (s-AML) patients included in one of 13 European Organisation for Research and Treatment of Cancer (EORTC) collaborative AML trials using intensive remission-induction chemotherapy. Among 8858 patients treated between May 1986 and January 2008, 960 were identified as having s-AML, either after MDS (cohort A; n = 508), occurring after primary solid tumors or hematologic malignancies other than MDS (cohort B; n = 361), or after non-malignant conditions or with a history of toxic exposure (cohort C; n = 91). Median age was 64 years, 60 years and 61 years in cohort A, B and C, respectively. Among patients ≤60 years and classified in the cohorts A or B ( n = 367), the 5-year overall survival (OS) rate was 28%. There was a systematic improvement in the 5-year OS rate over three time periods ( p < 0.001): 7.7% (95% CI: 1.3-21.7%) for patients treated before 1990 (period 1: n = 26), 23.3% (95% CI: 17.1-30.0%) for those treated between 1990 and 2000 (period 2: n = 188) and 36.5% (95% CI: 28.7-44.3%) for those treated in 2000 or later (period 3: n = 153). In multivariate analysis, male gender (HR = 1.39; p = 0.01), WBC ≥ 25 × 10 9 /L (HR = 2.00; p < 0.0001), age 46-60 years (HR = 1.65; p < 0.001) and poor-risk cytogenetics (HR = 2.17; p < 0.0001) were independently associated with shorter OS, while being treated during period 2 (HR = 0.50, p = 0.003) or period 3 (HR = 0.43; p = 0.0008). Having received high-dose cytarabine (HD-AraC) ( n = 48) in the induction chemotherapy (HR = 0.54, p = 0.012) was associated with a longer OS. In contrast, among patients >60 years of age ( n = 502), the OS was dismal, and there was no improvement over time.